non-Hodgkin lymphoma

Victoria SochaKidney Transplantation | February 5, 2024

Non-Hodgkin lymphoma (NHL) that develops following pediatric kidney transplantation is characterized as a ...

Rob DillardHematology | August 31, 2023

When physicians suspect a diagnosis of certain conditions, a referral to a hematologist is warranted.

DocWire News EditorsASH Annual Meeting 2020 | April 6, 2023

Odronextamab is a first-in-class, hinge-stabilized, fully human immunoglobulin G4-based CD3xCD20 bispecific antibody ...

DocWire News EditorsASH Annual Meeting 2020 | April 6, 2023

Researchers assessed the efficacy of adding selinexor to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, ...

Rob DillardOncology | January 27, 2023

Some pigmentation traits are associated with non-Hodgkin lymphomas (NHL) and chronic lymphocytic leukemia (CLL), ...

Kaitlyn D’OnofrioOncology | October 20, 2020

Jeff Bridges has been diagnosed with lymphoma, the actor announced on Twitter Monday evening. ...

Kerri FitzgeraldOncology | June 27, 2023

An anti-CD19 chimeric antigen receptor (CAR) T-cell-transduced natural killer (NK) therapy induced responses in patients ...

Kaitlyn D’OnofrioRheumatoid Arthritis | May 2, 2023

A new systematic review compared biosimilar rituximab to the originator drug in patients with rheumatoid arthritis (RA) ...

Kaitlyn D’OnofrioOncology | August 9, 2019

The Centers for Medicare & Medicaid Services (CMS) announced that chimeric antigen receptor (CAR) T-cell therapies, a ...

DocWire News EditorsOncology | July 24, 2019

A phase I study published in Blood found that treatment with a CD19-specific chimeric antigen receptor (CAR) T-cell ...

Kerri FitzgeraldOncology | August 13, 2018

A jury awarded Dewayne Johnson, a 46-year-old man with non-Hodgkin lymphoma, $289 million after the former school ...

Kerri FitzgeraldOncology | August 8, 2018

The FDA approved mogamulizumab-kpkc for adults with relapsed/refractory mycosis fungoides (MF) or Sézary syndrome ...